Mutational signature dynamics indicate SARS-CoV-2's evolutionary capacity is driven by host antiviral molecules.
Kieran D. LambMartha M. LukaMegan SaathoffRichard J. OrtonMy V. T. PhanMatthew CottenKe YuanDavid L. RobertsonPublished in: PLoS Comput. Biol. (2024)
Keyphrases